DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Moiseyev VS. et al.
Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN).
Eur Heart J 2002;
23: 1422-1432
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.